 | CUTANEOUS NEUROIMMUNOMODULATION: THE PROOPIOMELANOCORTIN SYSTEM
Copyright © 1999 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 885:57-74 (1999)
© 1999 New York Academy of Sciences
The Subtilisin/Kexin Family of Precursor Convertases: Emphasis on PC1, PC2/7B2, POMC and the Novel Enzyme SKI-1
NABIL G. SEIDAHa,
SUZANNE BENJANNETb,
JOSÉE HAMELINa,
AIDA M. MAMARBACHIa,
AJOY BASAKa,c,
JADWIGA MARCINKIEWICZb,
MAJAMBU MBIKAYb,
MICHEL CHRÉTIENb,c AND
MIECZYSLAW MARCINKIEWICZb
aLaboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, 110 Pine Ave. West, Montreal, QC, Canada H2W 1R7 bLaboratory of Molecular Neuroendocrinology, Clinical Research Institute of Montreal, 110 Pine Ave. West, Montreal, QC, Canada H2W 1R7
cPresent address: Loeb Health Research Institute at the Ottawa Hospital, 725 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 4K9.
Proopiomelanocortin (POMC) is a precursor to various, bioactive peptides including ACTH, ßLPH,  MSH, and ßendorphin (ßEND). Processing of POMC at dibasic residues is tissue-specific and is performed by either PC1 alone (resulting in ACTH and ßLPH, anterior pituitary corticotrophes) or by a combination of PC1 and PC2 (yielding  MSH and ßEND, pituitary neurointermediate lobe and hypothalamus). The PC2-specific binding protein 7B2 is intimately involved in the zymogen activation of proPC2 into PC2. Structure-function studies of these enzymes demonstrated the presence of N- and C-terminal domains, as well as specific amino acids within the catalytic segment that influence the degree of activity of each enzyme and the interaction of PC2 with 7B2. The tissue distribution, plasticity of expression, and the multiple precursors that are differentially cleaved by PC1 and/or PC2, predict a wide array of combinatorial activities of these convertases within the endocrine and neuroendocrine system. The phenotypic consequences of the absence of genetic expression of either PC1 or PC2 are now explored using knockout mice and in human patients suffering from obesity and diabetes.
This article has been cited by other articles:

|
 |

|
 |
 
T. Brzoska, T. A. Luger, C. Maaser, C. Abels, and M. Bohm
{alpha}-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
Endocr. Rev.,
August 1, 2008;
29(5):
581 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Spencer, N. C. J. Gibbons, M. Bohm, and K. U. Schallreuter
The Ca2+-Binding Capacity of Epidermal Furin Is Disrupted by H2O2-Mediated Oxidation in Vitiligo
Endocrinology,
April 1, 2008;
149(4):
1638 - 1645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A Luger and T. Brzoska
{alpha}-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs
Ann Rheum Dis,
November 1, 2007;
66(suppl_3):
iii52 - iii55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Nillni
Regulation of Prohormone Convertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin
Endocrinology,
September 1, 2007;
148(9):
4191 - 4200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perello, R. C. Stuart, and E. A. Nillni
Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1348 - E1357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wong, S. N. Albright, and M. F. Wolfner
Evidence for structural constraint on ovulin, a rapidly evolving Drosophila melanogaster seminal protein
PNAS,
December 5, 2006;
103(49):
18644 - 18649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon
Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells
Endocrinology,
March 1, 2006;
147(3):
1408 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bohm, M. Eickelmann, Z. Li, S. W. Schneider, V. Oji, S. Diederichs, G. S. Barsh, A. Vogt, K. Stieler, U. Blume-Peytavi, et al.
Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of {alpha}-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells
Endocrinology,
November 1, 2005;
146(11):
4635 - 4646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jing, E. A. Nillni, V. C. Sanchez, R. C. Stuart, and D. J. Good
Deletion of the Nhlh2 Transcription Factor Decreases the Levels of the Anorexigenic Peptides {alpha} Melanocyte-Stimulating Hormone and Thyrotropin-Releasing Hormone and Implicates Prohormone Convertases I and II in Obesity
Endocrinology,
April 1, 2004;
145(4):
1503 - 1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton
Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
Pharmacol. Rev.,
March 1, 2004;
56(1):
1 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Mousa, M. Shakibaei, N. Sitte, M. Schafer, and C. Stein
Subcellular Pathways of {beta}-Endorphin Synthesis, Processing, and Release from Immunocytes in Inflammatory Pain
Endocrinology,
March 1, 2004;
145(3):
1331 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Thomas, P. Moffatt, P. Salois, M.-H. Gaumond, R. Gingras, E. Godin, D. Miao, D. Goltzman, and C. Lanctot
Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype
J. Biol. Chem.,
December 12, 2003;
278(50):
50563 - 50571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Krude, H. Biebermann, D. Schnabel, M. Z. Tansek, P. Theunissen, P. E. Mullis, and A. Gruters
Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4633 - 4640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mzhavia, H. Pan, F.-Y. Che, L. D. Fricker, and L. A. Devi
Characterization of Endothelin-converting Enzyme-2. IMPLICATION FOR A ROLE IN THE NONCLASSICAL PROCESSING OF REGULATORY PEPTIDES
J. Biol. Chem.,
April 18, 2003;
278(17):
14704 - 14711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dey, X. Xhu, R. Carroll, C. W. Turck, J. Stein, and D. F. Steiner
Biological Processing of the Cocaine and Amphetamine-regulated Transcript Precursors by Prohormone Convertases, PC2 and PC1/3
J. Biol. Chem.,
April 18, 2003;
278(17):
15007 - 15014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Pulichino, S. Vallette-Kasic, C. Couture, Y. Gauthier, T. Brue, M. David, G. Malpuech, C. Deal, G. Van Vliet, M. De Vroede, et al.
Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency
Genes & Dev.,
March 15, 2003;
17(6):
711 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Y. M. Rayburn, H. C. Gooding, S. P. Choksi, D. Maloney, A. R. Kidd III, D. E. Siekhaus, and M. Bender
amontillado, the Drosophila Homolog of the Prohormone Processing Protease PC2, Is Required During Embryogenesis and Early Larval Development
Genetics,
January 1, 2003;
163(1):
227 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, J. E. Ippolito, E. M. Garabedian, P. A. Humphrey, and J. I. Gordon
Molecular Characterization of a Metastatic Neuroendocrine Cell Cancer Arising in the Prostates of Transgenic Mice
J. Biol. Chem.,
November 8, 2002;
277(46):
44462 - 44474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Challis, L. E. Pritchard, J. W.M. Creemers, J. Delplanque, J. M. Keogh, J.'a. Luan, N. J. Wareham, G. S.H. Yeo, S. Bhattacharyya, P. Froguel, et al.
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism
Hum. Mol. Genet.,
August 15, 2002;
11(17):
1997 - 2004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Sarac, S. Windeatt, M. G. Castro, and I. Lindberg
Intrapituitary Adenoviral Administration of 7B2 Can Extend Life Span and Reverse Endocrinological Deficiencies in 7B2 Null Mice
Endocrinology,
June 1, 2002;
143(6):
2314 - 2323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Dong and R. Day
Gene Expression of Proprotein Convertases in Individual Rat Anterior Pituitary Cells and Their Regulation in Corticotrophs Mediated by Glucocorticoids
Endocrinology,
January 1, 2002;
143(1):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Vayssie, N Garreau de Loubresse, and L Sperling
Growth and form of secretory granules involves stepwise assembly but not differential sorting of a family of secretory proteins in Paramecium
J. Cell Sci.,
January 3, 2001;
114(5):
875 - 886.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Li, E. Jansen, G. A. Brent, and T. C. Friedman
Regulation of prohormone convertase 1 (PC1) by thyroid hormone
Am J Physiol Endocrinol Metab,
January 1, 2001;
280(1):
E160 - E170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Haycock, S. J. Rowe, S. Cartledge, A. Wyatt, G. Ghanem, R. Morandini, I. G. Rennie, and S. MacNeil
alpha -Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines
J. Biol. Chem.,
May 19, 2000;
275(21):
15629 - 15636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. LUGER, T. BRZOSKA, T. E. SCHOLZEN, D.-H. KALDEN, C. SUNDERKOTTER, C. ARMSTRONG, and J. ANSEL
The Role of {alpha}-MSH as a Modulator of Cutaneous Inflammation
Ann. N.Y. Acad. Sci.,
January 1, 2000;
917(1):
232 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
PNAS,
October 23, 2001;
98(22):
12701 - 12705.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|